Momenta Pharmaceuticals, Inc. (MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will present at the Cowen 40th Annual Health Care Conference. The presentation is scheduled for Tuesday, March 3, 2020 at 10:40 A.M. ET. A webcast of the presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com.
Momenta Pharmaceuticals, Inc. (MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will release its financial results for the first quarter ended March 31, 2020 before the U.S. financial markets open on Thursday, May 7, 2020. Management will host a conference call on May 7, 2020 at 8:30 a.m. ET to discuss these results and provide an update on the company. A live webcast of the call will be available on the "Investors" section of the company's website, www.momentapharma.com.
Momenta Pharmaceuticals, Inc. (MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today provided an update on the Company’s clinical trial activities and business operations in light of the COVID-19 pandemic. During these challenging times, our utmost priority is the health and safety of patients in our clinical studies and the healthcare professionals who care for them, as well as our team.
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) investors will be delighted, with the company turning in some strong...
Momenta (MNTA) delivered earnings and revenue surprises of -49.12% and 64.43%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shareholders will have a reason to smile today, with the analysts making...
-- Reported favorable interim data from Phase 1/2 study of M254 in ITP, supporting expansion of Part B; expect to report updated data in Q2 2020 and launch additional Phase 2.
The small-cap healthcare companies are benefiting from the 2020 presidential election campaign, which has put pressure on the large cap cousins on how to overhaul the industry.
Momenta (MNTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Many biotech companies have been surging and the SPDR Biotech ETF has broken out over the highs of 2018-2020. Let's check out the charts of Momenta Pharmaceuticals , a biotechnology company with a scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. In this daily bar chart of MNTA, below, we can see that prices have made new highs for the move up.
At this time, I would like to welcome everyone to the Momenta Pharmaceuticals First Quarter 2020 Earnings Teleconference call. At this time, I would like to turn the call over to our first host, Patty Eisenhaur. Thank you, Jake, and good morning, everyone, and thank you for joining us today for Momenta's conference call to discuss financial results and operational highlights for the first quarter of 2020.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Q1 2020 Momenta Pharmaceuticals Inc Earnings Call
Momenta (MNTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
As you might know, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) just kicked off its latest annual results with some...
Q4 2019 Momenta Pharmaceuticals Inc Earnings Call
Momenta (MNTA) reports mixed Q4 results, with a wider-than-expected loss and revenues beating the same.
-- Top-line interim data from nipocalimab Vivacity-MG study expected by Q3 2020 -- -- Full data from Part B of Phase 1/2 study of M254 in ITP expected in Q3 2020 -- --.
Craig Wheeler has been the CEO of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) since 2006. This report will, first...
The pharmaceutical industry is part of the larger health care sector. Companies in the pharmaceutical industry research, develop, manufacture, and market medicines and drugs. The best-known pharmaceutical companies are, among others, Eli Lilly & Co.